(Total Views: 431)
Posted On: 09/13/2019 11:45:12 AM
Post# of 145254
Given the tight financial spot cytodyn was negotiating from, 90M milestone + 50% royalties, just for US HIV, I think they got a great deal, much higher than average. That 50% will quickly make up for a lower milestone. The 90M number would be 24c per share for every outstanding share, just on that deal alone, and people are selling at 39c right now.
![2102378693_royalrtes.jpg](https://investorshangout.com/images/MYImages/2102378693_royalrtes.jpg)
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)